This document outlines the Papua New Guinea National Department of Health's approved procedures for ordering cancer medicines for use in the Public Health service.
Version 1.0 - Published 27 August 2014
This document outlines the Papua New Guinea National Department of Health's approved procedures for ordering cancer medicines for use in the Public Health service.
Version 1.0 - Published 27 August 2014
This document outlines the Papua New Guinea National Department of Health's approved procedures for ordering cancer medicines for use in the Public Health service.
Version 1.0 - Published 27 August 2014
To check for updated version please visit http://www.scribd.com/CancerPNG Papua New Guinea Public Health Cancer Medicines Ordering Process Contents Background ....................................................................................................................................... 1 Feedback ........................................................................................................................................... 1 Processes .......................................................................................................................................... 2 Process One - Doctor to Doctor Ordering ....................................................................................... 2 Process Two - Fax Ordering ............................................................................................................ 2 Process Three - Pharmacy to Pharmacy Ordering ........................................................................... 2 Contact List ....................................................................................................................................... 2 National Cancer Treatment Centre, Angau Hospital, Lae ................................................................ 2 Pharmacy, Angau Hospital, Lae ...................................................................................................... 2 Pharmacy, Port Moresby General Hospital ..................................................................................... 3
Background The medicines ordering process is designed with more than one goal. Some of these goals are outlined below: To ensure timely delivery of cancer medicines To contribute to quality of treatment of cancer patients, by enabling consultation between the NCTC and the referring/treating doctor To ensure security of the procured medicines in terms of correct ordering/minimisation of medicines wastage/delivery of correct medicines to correct locations
The final responsibility for correct and timely ordering of medicines rests with the referring/treating doctor. That doctor should initiate the below procedures, follow up on outstanding tasks, and monitor the effectiveness of the procedure. If the doctor has concerns, they should address them with the NCTC and then upward through the relevant corporate structure if necessary. Feedback I have delegated the duty of collating and reporting on change requests to the Cancer Medicines Ordering Process to the Papua New Guinea Cancer Foundation (CFPNG). It should be clear that the CFPNG has no authority over the public health system's medicines ordering process, they are simply authorised to collate feedback on this process and deliver it to those with that authority. To that end, if you have feedback on this ordering process, please email Amy Carland on admin@cancerfoundation.org.pg or call on 7214 2816.
Version 1.0 - Released 25 August 2014 Page 2 of 3 To check for updated version please visit http://www.scribd.com/CancerPNG Processes Process One - Doctor to Doctor Ordering This is the preferred process for ordering cancer treatment medicines. The referring/treating doctor should contact Dr John Niblett (Director/Radiation Oncologist, NCTC) to discuss the medicines required on 7639 3409 or 472 6095 (ext 161). The requesting doctor should have on hand the details of the patient and the planned regime. Dr Niblett will then action next steps to deliver medicines for treatment.
In the case that Dr Niblett is not available, the requesting doctor should call the NCTC on 473 2121 and speak to the Registrar in attendance about their requirements. Process Two - Fax Ordering The requesting doctor prepares a fax that must include: Clinical details of the patient (including planned treatment regime) Mobile phone number of the requesting doctor
The requesting doctor must ensure that they remain contactable on their mobile phone to discuss the medicines order.
The fax order should be sent to 472 3969. Any fax orders should be followed up using the above contact details for doctor to doctor ordering. Process Three - Pharmacy to Pharmacy Ordering The requesting doctor should contact the pharmacy at PMGH (for instance, contact Winmary Bariamu) and inform the pharmacy of the medicine name, dosage/strength and quanity required. The PMGH pharmacy then contacts the pharmacy at Angau Hospital (Sebastian - 7318 2714) and request delivery of the medicines.
Dr Niblett must approve any order that transacts via the pharmacy. The pharmacist in Lae must contact Dr Niblett if the order appears unusual. Contact List Below is a list of contact details relevant to the cancer medicines ordering process. It is not comprehensive, and it would be helpful for additional contacts to be added/circulated between stakeholders (e.g. the PMGH pharmacy phone number). If you would like a phone number added to this list please email Amy at the CFPNG on admin@cancerfoundation.org.pg
National Cancer Treatment Centre, Angau Hospital, Lae Landlines: 472 6095 Ext 161 473 2121 Mobile: Dr John Niblett (Director/Radiation Oncologist) 7639 3409 Fax: 472 3969 Pharmacy, Angau Hospital, Lae Mobile: Sebastian 7318 2714
Version 1.0 - Released 25 August 2014 Page 3 of 3 To check for updated version please visit http://www.scribd.com/CancerPNG Pharmacy, Port Moresby General Hospital Mobile: Winmary Bariamu 7348 6154
Vertex Announces Positive Day 90 Data For The First Patient in The Phase 1 - 2 Clinical Trial Dosed With VX-880, A Novel Investigational Stem Cell-Derived Therapy For The Treatment of Type 1 Diabetes